Investors
To download our documents
Events
All events
Latest press releases
All press releases
Live stock price
OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris
ISIN
FR0012127173
Ticker
OSE
Type of listing
Continuous
Number of outstanding shares
22,463,262 shares as of December 31, 2025
Eligibility
Eligible to Long-Only Deferred Settlement Service
Financial calendar
This calendar is indicative and may be amended. Financial results are published after market close (Euronext Growth Paris).
April 29, 2026
2025 Full-Year Financial Update and Statements
April 30, 2026
2026 1Q Cash Position
June 24, 2026
Annual General Meeting
September 28, 2026
2026 First-Half Financial Update and Statements
October 27, 2026
2026 3Q Cash Position
January 26, 2027
2026 4Q Cash Position
